These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 12837120

  • 41. A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma.
    Bousquet J, Ben-Joseph R, Messonnier M, Alemao E, Gould AL.
    Clin Ther; 2002 Jan; 24(1):1-20. PubMed ID: 11833824
    [Abstract] [Full Text] [Related]

  • 42. Safety of inhaled corticosteroids in children with asthma.
    Bazzy-Asaad A.
    Curr Opin Pediatr; 2001 Dec; 13(6):523-7. PubMed ID: 11753100
    [Abstract] [Full Text] [Related]

  • 43. The properties of inhaled corticosteroids: similarities and differences.
    Barnes NC.
    Prim Care Respir J; 2007 Jun; 16(3):149-54. PubMed ID: 17530144
    [Abstract] [Full Text] [Related]

  • 44. Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: A comparison of ciclesonide and fluticasone propionate.
    Kaliner MA.
    Clin Ther; 2006 Mar; 28(3):319-31. PubMed ID: 16750447
    [Abstract] [Full Text] [Related]

  • 45. Evaluation of adrenocortical function in 3-7 aged asthmatic children treated with moderate doses of fluticasone propionate: reliability of dehydroepiandrosterone sulphate (dhea-s) as a screening test.
    Sahiner UM, Cetinkaya S, Ozmen S, Arslan Z.
    Allergol Immunopathol (Madr); 2011 Mar; 39(3):154-8. PubMed ID: 21257254
    [Abstract] [Full Text] [Related]

  • 46. Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Cox CA, Boudewijn IM, Vroegop SJ, Schokker S, Lexmond AJ, Frijlink HW, Hagedoorn P, Vonk JM, Farenhorst MP, Ten Hacken NHT, Kerstjens HAM, Postma DS, van den Berge M.
    Respir Med; 2017 Sep; 130():35-42. PubMed ID: 29206631
    [Abstract] [Full Text] [Related]

  • 47. Inhaled corticosteroids: Ocular safety and the hypothalamic-pituitary-adrenal axis.
    Carr WW, Szefler SJ.
    Ann Allergy Asthma Immunol; 2016 Dec; 117(6):589-594. PubMed ID: 27979014
    [Abstract] [Full Text] [Related]

  • 48. Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids.
    Daley-Yates PT, Aggarwal B, Plank M.
    Adv Ther; 2024 May; 41(5):1995-2009. PubMed ID: 38532238
    [Abstract] [Full Text] [Related]

  • 49. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
    Wolthers OD, Walters EG.
    Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone.
    Colice G, Martin RJ, Israel E, Roche N, Barnes N, Burden A, Polos P, Dorinsky P, Hillyer EV, Lee AJ, Chisholm A, von Ziegenweidt J, Barion F, Price D.
    J Allergy Clin Immunol; 2013 Jul; 132(1):45-54. PubMed ID: 23591272
    [Abstract] [Full Text] [Related]

  • 52. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model.
    Daley-Yates PT, Richards DH.
    Clin Ther; 2004 Nov; 26(11):1905-19. PubMed ID: 15639702
    [Abstract] [Full Text] [Related]

  • 53. Establishing a therapeutic index for the inhaled corticosteroids: part II. Comparisons of systemic activity and safety among different inhaled corticosteroids.
    Sorkness CA.
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 2):S52-64. PubMed ID: 9798723
    [Abstract] [Full Text] [Related]

  • 54. Effect of inhaled corticosteroids on bone mineral density in childhood asthma: comparison of fluticasone propionate with beclomethasone dipropionate.
    Gregson RK, Rao R, Murrills AJ, Taylor PA, Warner JO.
    Osteoporos Int; 1998 Oct; 8(5):418-22. PubMed ID: 9850348
    [Abstract] [Full Text] [Related]

  • 55. The treatment of asthma in children: inhaled corticosteroids.
    Ricciardolo FL.
    Pulm Pharmacol Ther; 2007 Oct; 20(5):473-82. PubMed ID: 16356743
    [Abstract] [Full Text] [Related]

  • 56. Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
    Wolthers OD, Moore A, Mersmann S, Dissanayake S.
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):373-380. PubMed ID: 28510491
    [Abstract] [Full Text] [Related]

  • 57. Inhaled corticosteroids in the treatment of respiratory allergy: safety vs. efficacy.
    Rizzo MC, Solé D.
    J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S198-205. PubMed ID: 17136296
    [Abstract] [Full Text] [Related]

  • 58. [Inhaled corticosteroid therapy in adults with asthma. Current evidences].
    Foresi A, Pelucchi A, Del Donno M, Marangio E, Olivieri D.
    Recenti Prog Med; 2005 Oct; 96(10):469-73. PubMed ID: 16491767
    [Abstract] [Full Text] [Related]

  • 59. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists.
    Creticos PS.
    Drugs; 2003 Oct; 63 Suppl 2():1-20. PubMed ID: 14984077
    [Abstract] [Full Text] [Related]

  • 60. Safety and efficacy of inhaled corticosteroids (ICS) in children with asthma.
    Petrisko MA, Skoner JD, Skoner DP.
    J Asthma; 2008 Oct; 45 Suppl 1():1-9. PubMed ID: 19093279
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.